Trials testing psychedelics for treating substance abuse disorders
Clinical Research News highlights addiction speaker series presentation
Clinical Research News highlighted a presentation from the University of Cincinnati's Davide Amato and Jon Kostas, executive director of the Association for Prescription Psychedelics, discussing current trials testing psychedelics to treat substance use disorders. Amato and Kostas spoke at the Center for Addiction Research's Summer Speaker Series Aug. 13.
Amato gave an overview of the history of psychedelics and research on their use to treat substance use disorder. He noted former names for the class of drugs such as "psychotomimetics" and "hallucinogens" can be misleading.
“In the context of psychosis, altered perception is very different,” said Amato, PhD, associate professor in UC's James L. Winkle College of Pharmacy. He said psychosis is diagnosed based on persistent symptoms including delusions and a loss of adherence to reality, while psychedelic experiences can be marked by increased ratings in positive attitudes, mood and social effects.
Amato and his colleagues are publishing research soon that summarizes current studies registered at ClinicalTrials.gov and identifies rebalancing of the brain’s dopamine system as the means by which psychedelics might help blunt drug-seeking behavior and promote drug abstinence. The article has been accepted for publication by the British Journal of Pharmacology.
Read the Clinical Research News article.
Featured photo at top of mushrooms. Photo/Christopher Ott/Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.